Lupin Ltd. Stock Sees Dip, But Remains Strong in Pharma Industry
Lupin Ltd., a leading pharmaceutical company, has seen a -3.04% dip in its stock price on April 19, 2024. This marks the second consecutive day of losses, with a total decline of -4.03% in the past two days. However, the stock has consistently outperformed the sector and has a positive long-term trend, making it a promising investment option.
Lupin Ltd., a leading pharmaceutical company in the largecap industry, has recently seen a dip in its stock price. On April 19, 2024, the company's stock lost -3.04%, underperforming the sector by -2.53%. This marks the second consecutive day of losses for Lupin Ltd., with a total decline of -4.03% in the past two days.
Despite this recent dip, Lupin Ltd. has been a reliable performer on MarketsMOJO since November 10, 2023. The stock has consistently outperformed the sector and has been recommended as a 'Buy' by MarketsMOJO.
On April 19, Lupin Ltd.'s stock touched an intraday low of Rs 1541.05, a decrease of -3.3%. However, the stock's moving averages are still higher than the 100-day and 200-day averages, indicating a positive trend in the long term. The stock is currently lower than the 5-day, 20-day, and 50-day moving averages.
In comparison to the overall market performance, Lupin Ltd. has underperformed the Sensex by -3.07% in the past day and -1.55% in the past month. However, the Sensex has only seen a slight increase of 0.28% and 0.94% in the same time periods, respectively.
Despite the recent dip in stock price, Lupin Ltd. remains a strong player in the pharma industry. With its consistent performance and positive long-term trend, the company continues to be a promising investment option for investors.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
